Sign in
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Search here...
Search
Subscribe
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Search here...
Search
Dose Daily News Bureau
facebook
instagram
linkedin
Exclusive Content
Sun Pharma’s $12B Organon Bid Signals India’s Boldest Global Pharma Expansion
Dose daily
Dose Daily News Bureau
-
April 11, 2026
Beyond Generics: Lupin Limited’s Dapagliflozin Approval Highlights Strategic Depth in Chronic Care
Dose daily
Dose Daily News Bureau
-
April 10, 2026
From Late Diagnosis to Early Detection: AI Initiative Targets Lung Cancer in Telangana
Dose daily
Dose Daily News Bureau
-
April 9, 2026
India’s Healthcare Landscape: Surgical Innovation Amid Infrastructure Challenges
Dose daily
Dose Daily News Bureau
-
April 7, 2026
Costly Cure: How the United States’ Drug Tariff Plan Could Reshape Global Healthcare
Dose daily
Dose Daily News Bureau
-
April 6, 2026
Generic Affordability at Risk: Jan Aushadhi Prices Set to Rise Amid Global Disruptions
Dose daily
Dose Daily News Bureau
-
April 4, 2026
1
...
20
21
22
...
41
Page 21 of 41
I want in
I've read and accept the
Privacy Policy
.
ICMR & NCDC Supports Kerala in Managing Nipah Case
Dose Daily News Bureau
-
June 15, 2026
FSSAI Bans Use of Metallic Pins and Wires in Food Packaging
Breaking News
Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats
Breaking News
Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order
Breaking News
FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes
Breaking News
The FDA has outlined its updated strategy for generic drug oversight
Breaking News
×